Labcorp Holdings Revenue 2012-2025 | LH
Labcorp Holdings annual/quarterly revenue history and growth rate from 2012 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Labcorp Holdings revenue for the quarter ending September 30, 2025 was $3.564B, a 8.58% increase year-over-year.
- Labcorp Holdings revenue for the twelve months ending September 30, 2025 was $13.765B, a 8.28% increase year-over-year.
- Labcorp Holdings annual revenue for 2024 was $13.009B, a 6.97% increase from 2023.
- Labcorp Holdings annual revenue for 2023 was $12.162B, a 2.51% increase from 2022.
- Labcorp Holdings annual revenue for 2022 was $11.864B, a 9.68% decline from 2021.
|
Labcorp Holdings Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $13,009 |
| 2023 | $12,162 |
| 2022 | $11,864 |
| 2021 | $13,136 |
| 2020 | $13,979 |
| 2019 | $11,555 |
| 2018 | $11,333 |
| 2017 | $10,308 |
| 2016 | $9,553 |
| 2015 | $8,680 |
| 2014 | $6,012 |
| 2013 | $5,808 |
| 2012 | $5,671 |
| 2011 | $5,542 |
|
Labcorp Holdings Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $3,564 |
| 2025-06-30 | $3,527 |
| 2025-03-31 | $3,345 |
| 2024-12-31 | $3,329 |
| 2024-09-30 | $3,282 |
| 2024-06-30 | $3,221 |
| 2024-03-31 | $3,177 |
| 2023-12-31 | $3,033 |
| 2023-09-30 | $3,057 |
| 2023-06-30 | $3,034 |
| 2023-03-31 | $3,038 |
| 2022-12-31 | $2,175 |
| 2022-09-30 | $2,867 |
| 2022-06-30 | $2,923 |
| 2022-03-31 | $3,900 |
| 2021-12-31 | $1,071 |
| 2021-09-30 | $4,063 |
| 2021-06-30 | $3,841 |
| 2021-03-31 | $4,162 |
| 2020-12-31 | $4,490 |
| 2020-09-30 | $3,896 |
| 2020-06-30 | $2,769 |
| 2020-03-31 | $2,824 |
| 2019-12-31 | $2,953 |
| 2019-09-30 | $2,929 |
| 2019-06-30 | $2,882 |
| 2019-03-31 | $2,791 |
| 2018-12-31 | $2,788 |
| 2018-09-30 | $2,831 |
| 2018-06-30 | $2,866 |
| 2018-03-31 | $2,848 |
| 2017-12-31 | $2,745 |
| 2017-09-30 | $2,621 |
| 2017-06-30 | $2,528 |
| 2017-03-31 | $2,414 |
| 2016-12-31 | $2,340 |
| 2016-09-30 | $2,415 |
| 2016-06-30 | $2,431 |
| 2016-03-31 | $2,368 |
| 2015-12-31 | $2,301 |
| 2015-09-30 | $2,317 |
| 2015-06-30 | $2,269 |
| 2015-03-31 | $1,793 |
| 2014-12-31 | $1,513 |
| 2014-09-30 | $1,552 |
| 2014-06-30 | $1,516 |
| 2014-03-31 | $1,431 |
| 2013-12-31 | $1,437 |
| 2013-09-30 | $1,462 |
| 2013-06-30 | $1,468 |
| 2013-03-31 | $1,441 |
| 2012-12-31 | $1,405 |
| 2012-09-30 | $1,419 |
| 2012-06-30 | $1,423 |
| 2012-03-31 | $1,423 |
| 2011-12-31 | $1,366 |
| 2011-09-30 | $1,405 |
| 2011-06-30 | $1,403 |
| 2011-03-31 | $1,368 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $24.032B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $155.383B | 28.20 |
| HCA Healthcare (HCA) | United States | $118.848B | 18.81 |
| CVS Health (CVS) | United States | $97.986B | 11.41 |
| Elevance Health (ELV) | United States | $72.888B | 10.95 |
| Cencora (COR) | United States | $70.943B | 22.38 |
| Natera (NTRA) | United States | $29.388B | 0.00 |
| DiDi Global (DIDIY) | China | $22.638B | 20.91 |
| Viatris (VTRS) | United States | $18.578B | 6.92 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.296B | 0.00 |
| Solventum (SOLV) | United States | $14.134B | 13.72 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.032B | 27.71 |
| CochLear (CHEOY) | Australia | $11.828B | 0.00 |
| Revvity (RVTY) | United States | $11.462B | 19.94 |
| ICON (ICLR) | Ireland | $10.752B | 10.67 |
| Charles River Laboratories (CRL) | United States | $8.169B | 15.73 |
| Sonic Healthcare (SKHHY) | Australia | $7.784B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.225B | 43.08 |
| Avantor (AVTR) | United States | $6.573B | 10.59 |
| HealthEquity (HQY) | United States | $6.572B | 24.58 |
| PACS (PACS) | United States | $6.136B | 37.31 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.066B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.034B | 39.60 |
| Sotera Health (SHC) | United States | $4.935B | 23.80 |
| Alignment Healthcare (ALHC) | United States | $4.080B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.098B | 19.34 |
| GeneDx Holdings (WGS) | United States | $2.643B | 46.42 |
| Establishment Labs Holdings (ESTA) | United States | $2.113B | 0.00 |
| Organon (OGN) | United States | $1.999B | 2.11 |
| Surgery Partners (SGRY) | United States | $1.940B | 25.00 |
| Progyny (PGNY) | United States | $1.858B | 36.53 |
| Pediatrix Medical (MD) | United States | $1.844B | 11.01 |
| Ardent Health (ARDT) | United States | $1.339B | 4.37 |
| InnovAge Holding (INNV) | United States | $1.110B | 163.60 |
| CareDx (CDNA) | United States | $1.014B | 16.57 |
| Teladoc Health (TDOC) | United States | $0.831B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.757B | 12.39 |
| Nutex Health (NUTX) | United States | $0.728B | 5.57 |
| Sonida Senior Living (SNDA) | United States | $0.651B | 0.00 |
| Omada Health (OMDA) | United States | $0.634B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.606B | 0.00 |
| Embecta (EMBC) | United States | $0.596B | 3.32 |
| Enhabit (EHAB) | United States | $0.569B | 25.55 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.476B | 8.75 |
| CryoPort (CYRX) | United States | $0.426B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Strata Critical Medical (SRTA) | United States | $0.384B | 0.00 |
| So-Young (SY) | China | $0.373B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.360B | 5.79 |
| Oncology Institute (TOI) | United States | $0.258B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.252B | 0.00 |
| Agilon Health (AGL) | United States | $0.158B | 0.00 |
| LifeMD (LFMD) | United States | $0.140B | 0.00 |
| Beauty Health (SKIN) | United States | $0.135B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.110B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.100B | 0.00 |
| Biodesix (BDSX) | United States | $0.082B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.079B | 0.00 |
| DocGo (DCGO) | United States | $0.071B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.041B | 0.00 |
| Pomdoctor - (POM) | China | $0.024B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.019B | 5.97 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |